258 related articles for article (PubMed ID: 32272490)
1. Truncation of CXCL8 to CXCL8(9-77) enhances actin polymerization and in vivo migration of neutrophils.
Metzemaekers M; Vandendriessche S; Berghmans N; Gouwy M; Proost P
J Leukoc Biol; 2020 Jun; 107(6):1167-1173. PubMed ID: 32272490
[TBL] [Abstract][Full Text] [Related]
2. Biological activity of CXCL8 forms generated by alternative cleavage of the signal peptide or by aminopeptidase-mediated truncation.
Mortier A; Berghmans N; Ronsse I; Grauwen K; Stegen S; Van Damme J; Proost P
PLoS One; 2011; 6(8):e23913. PubMed ID: 21904597
[TBL] [Abstract][Full Text] [Related]
3. Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties.
Vacchini A; Mortier A; Proost P; Locati M; Metzemaekers M; Borroni EM
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486423
[TBL] [Abstract][Full Text] [Related]
4. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
[TBL] [Abstract][Full Text] [Related]
5. Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration.
Hu N; Westra J; Rutgers A; Doornbos-Van der Meer B; Huitema MG; Stegeman CA; Abdulahad WH; Satchell SC; Mathieson PW; Heeringa P; Kallenberg CG
Arthritis Res Ther; 2011; 13(6):R201. PubMed ID: 22152684
[TBL] [Abstract][Full Text] [Related]
6. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
7. NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
Wuyts A; D'Haese A; Cremers V; Menten P; Lenaerts JP; De Loof A; Heremans H; Proost P; Van Damme J
J Immunol; 1999 Dec; 163(11):6155-63. PubMed ID: 10570306
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2.
Casilli F; Bianchini A; Gloaguen I; Biordi L; Alesse E; Festuccia C; Cavalieri B; Strippoli R; Cervellera MN; Di Bitondo R; Ferretti E; Mainiero F; Bizzarri C; Colotta F; Bertini R
Biochem Pharmacol; 2005 Feb; 69(3):385-94. PubMed ID: 15652230
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human T cells that regulate neutrophilic skin inflammation.
Schaerli P; Britschgi M; Keller M; Steiner UC; Steinmann LS; Moser B; Pichler WJ
J Immunol; 2004 Aug; 173(3):2151-8. PubMed ID: 15265952
[TBL] [Abstract][Full Text] [Related]
10. A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation.
Martínez-Burgo B; Cobb SL; Pohl E; Kashanin D; Paul T; Kirby JA; Sheerin NS; Ali S
Immunology; 2019 Jun; 157(2):173-184. PubMed ID: 31013364
[TBL] [Abstract][Full Text] [Related]
11. Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
Souto FO; Zarpelon AC; Staurengo-Ferrari L; Fattori V; Casagrande R; Fonseca MJ; Cunha TM; Ferreira SH; Cunha FQ; Verri WA
J Nat Prod; 2011 Feb; 74(2):113-8. PubMed ID: 21275387
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8: An evolving chemokine.
Matsushima K; Yang D; Oppenheim JJ
Cytokine; 2022 May; 153():155828. PubMed ID: 35247648
[TBL] [Abstract][Full Text] [Related]
13. Porcine CXCR1/2 antagonist CXCL8
Wang X; Li Y; Li L; Jiao Z; Liu X; Cheng G; Gu C; Hu X; Zhang W
Sci Rep; 2020 Jan; 10(1):1210. PubMed ID: 31988368
[TBL] [Abstract][Full Text] [Related]
14. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
15. The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.
Vanheule V; Janssens R; Boff D; Kitic N; Berghmans N; Ronsse I; Kungl AJ; Amaral FA; Teixeira MM; Van Damme J; Proost P; Mortier A
J Biol Chem; 2015 Aug; 290(35):21292-304. PubMed ID: 26183778
[TBL] [Abstract][Full Text] [Related]
16. Cell migration to the chemokine CXCL8: paxillin is activated and regulates adhesion and cell motility.
Cohen-Hillel E; Mintz R; Meshel T; Garty BZ; Ben-Baruch A
Cell Mol Life Sci; 2009 Mar; 66(5):884-99. PubMed ID: 19151925
[TBL] [Abstract][Full Text] [Related]
17. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8
Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW
Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019
[TBL] [Abstract][Full Text] [Related]
18. A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP.
Goldblatt J; Lawrenson RA; Muir L; Dattani S; Hoffland A; Tsuchiya T; Kanegasaki S; Sriskandan S; Pease JE
J Immunol; 2019 Jun; 202(11):3246-3255. PubMed ID: 31010851
[TBL] [Abstract][Full Text] [Related]
19. A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage.
Bedke J; Nelson PJ; Kiss E; Muenchmeier N; Rek A; Behnes CL; Gretz N; Kungl AJ; Gröne HJ
Mol Immunol; 2010 Feb; 47(5):1047-57. PubMed ID: 20004976
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
